Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PG201 in Osteoarthritis of the Knee
NCT01576419Phase 3Completed
- Sponsor
- PMG Pharma
- Start
- Jan 2010
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of PG201 in knee osteoarthritis (OA), sponsored by PMG Pharma. Started Jan 2010; status: completed.
02
Drugs
PG201
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT01576419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01576419.